Hovione Partners with Microinnova to Advance Modular Flow Chemistry Manufacturing Technology
核心洞察
Hovione and Microinnova Engineering (搜索) have formed a strategic partnership to test and develop multi-purpose, plug-and-play modular equipment for flow chemistry in pharmaceutical manufacturing.
The collaboration aims to accelerate process development and enable seamless transition from laboratory to large-scale manufacturing, ultimately reducing time to market for pharmaceutical customers.
Microinnova's modular manufacturing equipment is designed to offer greater flexibility, easier scalability, enhanced efficiency, and sustainable practices in active ingredient production.
Hovione, an international integrated pharmaceutical development and manufacturing company with over 60 years of experience, has announced a strategic partnership with Microinnova Engineering (搜索) to advance modular flow chemistry manufacturing technology. The collaboration focuses on testing and developing multi-purpose, plug-and-play modular equipment designed to transform pharmaceutical manufacturing processes.
Partnership Objectives and Technology Focus
The companies will work together to test Microinnova Engineering (搜索)'s modular manufacturing equipment in an industrial setting. The technology is specifically designed to offer greater flexibility, easier scalability, enhanced efficiency, and sustainable practices in active ingredient production. The partnership aims to achieve faster process development, enable simple transition from laboratory to large-scale manufacturing, and ultimately decrease time to market for pharmaceutical customers.
"This collaboration with Microinnova underscores Hovione's commitment to innovation in pharmaceutical manufacturing, with flow chemistry playing an important role in our long-term drug substance strategy," said Dr. Jean-Luc Herbeaux, CEO of Hovione. "This partnership will allow us to shape and validate emerging continuous manufacturing technologies, which can potentially accelerate drug development and production."
Industry Expertise and Capabilities
Microinnova Engineering (搜索) brings significant expertise to the partnership, with more than 20 years of experience in flow chemistry and process intensification, along with over 250 successfully completed projects. The company specializes in modular continuous plants and scales processes from laboratory tests to tons-per-hour production, enabling rapid time-to-market and manufacturing flexibility.
Dr. Dirk Kirschneck, founder and strategic director at Microinnova, emphasized the strategic alignment of the partnership. "This partnership reflects our shared vision to deliver modular manufacturing technologies that support pharmaceutical innovation and manufacturing excellence. We are proud to join forces with Hovione to showcase the capabilities of our next-generation modular equipment in a dynamic CDMO environment, demonstrating its versatility for multi-purpose manufacturing."
Manufacturing Infrastructure and Standards
Hovione operates as a contract development and manufacturing organization with a fully integrated offering of services for drug substances, drug product intermediates, and drug products. The company maintains four US FDA inspected sites in the USA, Portugal, Ireland, and China, along with development laboratories in Lisbon, Portugal and New Jersey, USA.
Microinnova operates as an ISO 9001:2015-certified company and designs plants that meet GMP and ATEX standards for quality and safety. The company's team uses process intensification techniques and selects the most advantageous technology for each process, even in regulated environments, providing process development as well as pilot plant and manufacturing plant solutions.
Strategic Impact on Pharmaceutical Manufacturing
The partnership represents a significant step toward advancing continuous manufacturing technologies in the pharmaceutical industry. By combining Hovione's extensive manufacturing experience and regulatory expertise with Microinnova's specialized modular equipment technology, the collaboration aims to demonstrate the practical application of next-generation manufacturing solutions in a dynamic CDMO environment.